[Clinical comparison of capreomycin and kanamycin, with special reference to the effects of CPM in the KM-resistant cases].
D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D006801:Humans; D007612:Kanamycin / Q000009:adverse effects / Q000627:therapeutic use*; D009169:Mycobacterium tuberculosis / Q000187:drug effects
D000995:Antitubercular Agents; D007612:Kanamycin